U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07131241) titled 'PH-DyPred: A Multimodal Dynamic Risk Prediction Study in Pulmonary Hypertension' on Aug. 06.
Brief Summary: Pulmonary hypertension (PH) is a progressive cardiopulmonary disease characterized by elevated pulmonary artery pressure and vascular remodeling, which leads to right heart failure and increased mortality. Despite advances in diagnostics, risk stratification remains limited due to the disease's heterogeneity. This study aims to develop and validate a dynamic risk prediction model for PH by integrating multimodal data-including echocardiography, Cardiac MRI, PET-MR, ECG, biomarkers, and clinical features-using advanced machine ...